Mosunetuzumab

Generic name: Mosunetuzumab
Brand names: Lunsumio
Dosage form: intravenous solution (axgb 1 mg/mL; axgb 30 mg/30 mL)
Drug class: Miscellaneous antineoplastics

Usage of Mosunetuzumab

Mosunetuzumab is used to treat follicular lymphoma (a cancer of the lymphatic system) in adults whose cancer has returned or did not respond to another treatment and who have received at least two previous cancer treatments.

Mosunetuzumab may also be used for purposes not listed in this medication guide.

Mosunetuzumab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Tell your medical caregivers if you have signs of cytokine release syndrome (CRS), a serious side effect: fever, chills, trouble breathing, confusion, severe vomiting or diarrhea, fast or irregular heartbeats, feeling light-headed or very tired.

Mosunetuzumab may cause serious side effects. Call your doctor at once if you have:

signs and symptoms of nervous system disorders--headache; numbness or tingling in arms, legs, hands, or feet; dizziness, confusion, or disorientation; problems with balance, coordination, or muscle movement; sleepiness or sleeping problems; amnesia or forgetfulness; trouble speaking, writing, or reading; or seizures;

low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;

signs or symptoms of tumor related problems--chest pain, cough, breathing problems, tender or swollen lymph nodes, pain or swelling at tumor site; or

signs of infection--fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding.

Common side effects of mosunetuzumab may include:

abnormal lab results;

tiredness;

rash;

fever; or

headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Mosunetuzumab

Tell your doctor if you have or have ever had:

an infusion reaction after receiving mosunetuzumab;

an infection or an infection that lasts a long time or keeps returning; or

Epstein-Barr Virus (mononucleosis).

You may need to have a negative pregnancy test before starting this treatment.

May harm an unborn baby. Do not use if you are pregnant. Use effective birth control while using mosunetuzumab and for at least 3 months after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed while using mosunetuzumab, and for at least 3 months after your last dose.

Relate drugs

How to use Mosunetuzumab

Usual Adult Dose for Follicular Lymphoma:

Cycle oneDay 1: IV infusion of 1mg once over at least 4 hoursDay 8: IV infusion of 2mg once over at least 4 hoursDay 15: IV infusion of 60mg once over at least 4 hoursCycle twoDay 1: IV infusion of 60mg once over at least 2 hours if infusions from Cycle 1 were well-toleratedCycle three onwardsDay 1: IV infusion of 30mg once over at least 2 hours if infusions from Cycle 1 were well-toleratedDuration of therapy: Treatment duration based on complete or partial response unless unacceptable toxicity or disease progression occurs:-Patients with complete response: 8 cycles -Patients with partial response: 17 cycles total (8 initial cycles + 9 more cycles)Comments:-Premedicate before each dose during Cycle 1 and Cycle 2; ensure adequate hydration prior to administering this drug.-Do not use an in-line filter to administer this drug.-Patients who achieved a partial response or stable disease after 8 cycles of treatment with this drug are eligible for an additional 9 cycles of treatment (17 cycles total) unless they experience unacceptable toxicity or disease progression.-Refer to the manufacturer's prescribing information for premedication and recommendations for restarting therapy with this drug after a dose delay.Use: For the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy

Warnings

Tell your medical caregivers if you have symptoms of a serious side effect, such as fever, chills, trouble breathing, vomiting, or severe tiredness.

Call your doctor if you have signs and symptoms of neurological problems such as headache, dizziness, tremors, problems walking, confusion and disorientation, muscle problems or weakness.

Also call your doctor if you have signs of infection such as fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding

What other drugs will affect Mosunetuzumab

Other drugs may affect mosunetuzumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.